Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NMRC submits revised IND to FDA to conduct RESUS clinical trial of Biopure's Hemopure

March 24, 2009

Transition initiates phase Ib TT-223/GLP-1 analogue study in type 2 diabetes

March 24, 2009

Novel clinical candidate for type 2 diabetes treatment described by Amgen

March 24, 2009

CHMP recommends marketing authorization for HRA's emergency contraceptive ellaOne

March 24, 2009

Clinical trial results for MB-07803 in type 2 diabetes reported by Metabasis

March 24, 2009

Merck presents novel selective androgen receptor modulator

March 23, 2009

Pfizer reports on development, pharmacological profile of PF-2413873

March 23, 2009

FDA issues letter to Oxygen outlining path forward to resume clinical studies of Oxycyte

March 23, 2009

Lipoxen and Glide collaborate to investigate delivery of SuliXen with Glide technology

March 23, 2009

MHRA accepts BioMarin's CTA for phase I/II clinical trial of BMN-110 in MPS IVA

March 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...